Izun Pharmaceuticals Ltd. is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments.
The Company’s core technology utilizes naturally derived pharmaceutical actives for the treatment of oral disease with inflammatory components. The novel therapies contain multiple synergistic metabolites and multiple therapeutic effects. The Company follows a market driven product development strategy focusing on multi-billion dollar markets with unmet medical needs for effective oral therapeutics. Izun Pharmaceuticals’ research and development pipeline provides innovative products suitable for a wide range of oral health care needs, from O.T.C. through prescription medicines based on combination plant extracts.
To develop innovative topical drugs and products based on botanical sources addressing major,under-served markets.